Navigation Links
Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Date:5/18/2009

m control
  • 4 out of 5 Alair-treated patients responded with a clinically significant improvement in AQLQ compared to 64% of sham controls
  • 32% reduction in asthma attacks
  • 84% reduction in emergency room visits for respiratory symptoms
  • 36% reduction in patients reporting episodes of asthma (multiple symptoms) adverse events
  • 66% reduction in days lost from work/school or other activities due to respiratory symptoms

  • In the period immediately following bronchial thermoplasty, there is an expected increase and worsening of respiratory-related symptoms, which are of the type expected following bronchoscopy in patients with asthma. These events typically occur within a day of the procedure and resolve on average within 7 days with standard care. In the long term, fewer bronchial thermoplasty treated patients reported respiratory adverse events and there was a significant decrease in patients reporting asthma (multiple symptoms) adverse events in the Alair-treated group compared to the sham control group.

    "The results from AIR2, similar to the results from two prior randomized clinical trials evaluating the Alair System, demonstrate that patients with severe asthma can experience clinically significant improvements in their asthma control and their quality of life," said Glen French, CEO of Asthmatx.

    The results of this pivotal study have enabled Asthmatx to submit a Premarket Approval application (PMA) to the FDA for regulatory approval. The FDA granted the Alair System PMA Expedited Review Status in October 2008, based on its potential "to treat asthma, a life-threatening/debilitating disease" and because the "Alair System offers a breakthrough technology which has the potential to address an unmet clinical need within the asthma population."

    "Participation in the AIR2 Trial required a
    '/>"/>

    SOURCE Asthmatx, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
    2. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
    3. Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
    4. Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
    5. QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
    6. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
    7. Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
    8. VirtualScopics Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial
    9. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
    10. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
    11. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... July 30, 2015 PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the second quarter ending June ... many fronts across the organization.  We are excited to ... dystrophy clinical trial ever conducted with topline results expected ... Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is now ...
    (Date:7/30/2015)... July 30, 2015  Cleveland Clinic President Wael ... address last month that industry is compelled to adopt ... gain the efficiencies—and develop the transformational innovations -- required ... comments were preceded by Doug Kohrs , past ... moderator, who stressed that industry must add "episode of ...
    (Date:7/30/2015)... VALLEY COTTAGE, New York , July 30, 2015 ... the release of its latest report titled, "Continuous Glucose ... 2015 - 2020". According to the report, the global ... 402.0 Mn in 2014 and is expected to reach ... 12.1% during the forecast period, 2015 to 2020. ...
    Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
    ... N.Y., June 23 A landmark study has ... failure or death in patients with heart disease ... with defibrillator (CRT-D) versus patients who received only ... , MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with ...
    ... LAUSANNE, Switzerland, June 23 Debiopharm Group,(Debiopharm), a ... the development of prescription drugs that target unmet medical,needs, ... Moapar(R),and Salvapar(R)), was launched in Germany in May 2009, ... also launched on a preliminary basis in,Belgium. The effective ...
    Cached Medicine Technology:New Therapy Found to Prevent Heart Failure 2Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries 2
    (Date:7/31/2015)... ... July 31, 2015 , ... ... logic applies when purchasing disability insurance, where price is an important factor to ... with a leading insurance carrier, offers the Preferred Producer Multi-Life Discount program, where ...
    (Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... apnea (OSA) and the growing number of individuals who remain undiagnosed, treatment options ... continue to shy away from traditional CPAP therapy due to its overall lack ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor ... speak at the International Cannabis Professionals Expo held at the Caribe Royal All Suites ... International Cannabis Professionals Expo is the largest medical cannabis expo in the country ...
    (Date:7/30/2015)... Providenciales, Turks & Caicos Islands, BWI (PRWEB) , ... July 31, 2015 , ... The ... special offer for fall, 2015. Guests who stay at the Venetian will save 40% ... , The fall months are always quiet in the Turks & Caicos, providing a ...
    (Date:7/30/2015)... ... , ... Committed to helping the next generation succeed - Mercy College is ... the College’s “My Brother’s Keeper Scholarship.” The President’s signature initiative issues a call to ... support they need to think more broadly about their future. Building on what works ...
    Breaking Medicine News(10 mins):Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3
    ... ... Mr. Ohad Goren will function as Pollogen,s CEO. Pollogen recently launched its latest technology- ... action - fat reduction. , ... Tel-Aviv, Israel (PRWEB) April 19, 2010 -- Pollogen Ltd , a ...
    ... ... accumulated medical records knowledge to offer a full Electronic Medical Records (EMR) data conversion ... ... in healthcare connectivity solutions, now offers a full range of EMR to EMR Data ...
    ... those who get something lodged in their throat die , ... young children who choke after swallowing a foreign object is ... real, the latest research indicates. , "In such cases, the ... K. Shah, a pediatric otolaryngologist with the Children,s National Medical ...
    ... first study of vitamin K and Non-Hodgkin lymphoma ... found that people who have higher intakes of vitamin K ... lymphoma. Non-Hodgkin Lymphoma is a cancer of the immune ... United States. At the 101st Annual Meeting ...
    ... SAN MARCOS, TXStudents, perceptions of their overall experience on ... accomplishments, but research has also found a solid relationship ... perceptions of quality of life. Are campus green spaces ... undergrads? A new study investigating this question revealed some ...
    ... screening, diagnosis , MONDAY, April 19 (HealthDay News) -- Researchers ... tests could be a sign that patients are at higher ... that in blacks, a common germ boosts the risk of ... often become cancerous. , Both studies are slated to be ...
    Cached Medicine News:Health News:Pollogen Ltd. Names Ohad Goren Chief Executive Officer 2Health News:Pollogen Ltd. Names Ohad Goren Chief Executive Officer 3Health News:ELLKAY Launches Electronic Medical Records (EMR) Conversion Division to Healthcare Industry 2Health News:ELLKAY Launches Electronic Medical Records (EMR) Conversion Division to Healthcare Industry 3Health News:Fatal Choking a Real Risk Among Toddlers 2Health News:Fatal Choking a Real Risk Among Toddlers 3Health News:Vitamin K may protect against developing non-Hodgkin's lymphoma, say Mayo Clinic researchers 2Health News:Vitamin K may protect against developing non-Hodgkin's lymphoma, say Mayo Clinic researchers 3Health News:Campus green space more important for undergrads 2Health News:New Risk Factors for Colon Cancer Studied 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: